Clinical trial
A Phase IIB Placebo Comparative, Double Blinded, Randomized, Multi-center Study to Evaluate the Efficacy and Safety of ALbumin Therapy in Acute Ischemic Stroke Patients in Korea.
NCT01684462 is registered in ClinicalTrials.gov with Seoul St. Mary's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIB Placebo Comparative, Double Blinded, Randomized, Multi-center Study to Evaluate the Efficacy and Safety of ALbumin Therapy in Acute Ischemic Stroke Patients in Korea.
- Lead sponsor
- Seoul St. Mary's Hospital
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2012
- Completion date
- September 30, 2014
- Enrollment
- 2 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.